Please login to the form below
American College of Cardiology
This page shows the latest American College of Cardiology news and features for those working in and with pharma, biotech and healthcare.
Sanofi, Regeneron offer price cut for cholesterol drug Praluent
The offer has been made just after the presentation of the large-scale ODYSSEY OUTCOMES at the American College of Cardiology (ACC) meeting in Orlando, which showed that adding PCSK9 inhibitor ... be acceptable for the drug – depending on the
Latest news
-
AZ data suggest SGLT2 inhibitors can reduce heart failure risk
The CVD-REAL study – presented at the American College of Cardiology (ACC) meeting in Washington DC - examined patient records from 300, 000 people across six countries and found that treatment with ... patients with type 2 diabetes at the lower end of
-
Xarelto beats aspirin for recurrent blood clots
risk. The results of the EINSTEIN CHOICE trial looked at the value of extended treatment of patients with venous thromboembolism (VTE). ... The results were presented at the American College of Cardiology (ACC) meeting in Washington DC by Philip Wells of
-
Novartis launches heart failure social network
To that end the company worked with several US health advocacy organisations to set up Together in HF, among them the American Association of Heart Failure Nurses, CardioSmart by the American ... College of Cardiology and WomenHeart: The National
-
Cholesterol drugs could have striking benefits in stroke
hypothesis that lipid lowering may be effective in the primary prevention of stroke in older people.”. ... This followed 2013 guidelines from the American Heart Association and American College of Cardiology calling for a more nuanced approach to
-
AZ seeks leg up in antiplatelet market with Brilinta antidote
AZ's drug is now considered the preferred oral antiplatelet drug by the American Heart Association (AHA) and American College of Cardiology (ACC), and having an effective reversal agent could encourage ... on the road to meeting AZ's sales target of
More from news
Approximately 2 fully matching, plus 26 partially matching documents found.
Latest Intelligence
-
Interview: Allan Hillgrove, Boehringer
This interest in China expands beyond Lilly and diabetes, however, and Boehringer's additional efforts include educational partnerships, such as a joint effort with the Chinese Society of Cardiology and the ... American College of Cardiology (ACC) to
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
New head at Cardiovascular Research Foundation
Jack Lewin is former CEO of American College of Cardiology and the California Medical Association. ... A former CEO of both the American College of Cardiology and the California Medical Association, Lewin has also served as director of health for Hawaii,
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Account Director - Medical Communications - London / South East
-
Excellent Salary and Benefits on offer
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Account Director, Healthcare Communications
-
Salary TBC
-
Account Director – UK Office
-
Excellent salary and benefits
- FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...
-
Excellent Daily Rate
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
Subscribe to our email news alerts
- GSK hires Merck KGaA exec to lead US pharma business
- Novartis chooses internal replacement for US pharma president role
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Senators attack Novartis over 'unconscionable' handling of Zolgensma data
- Boris Johnson announces fast-track immigration plans for top scientists
- Lilly psoriasis drug beats J&J's Tremfya in head-to-head trial
- Blended Intelligence
- Planning a pharma exhibition stand? You must read this!
- Leaked no-deal Brexit document forecasts widespread shortages
- AbbVie scores FDA approval for arthritis treatment upadacitinib
- Novo Nordisk shareholder revolt reaches Europe
- BMS buoyed by FDA approval of Celgene’s myelofibrosis drug
PMHub
W2O Group
W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...
Latest intelligence
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
- The relevance of patient perspectives to value
- Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
- How is the NHS Long-term Plan being put into action?
- Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
Quick links
Infographics
